Search

Direct electrical stimulation (DES) is considered to be the gold standard for mapping cortical function. A careful mapping of the eloquent cortex is key to successful resective or ablative surgeries, with a minimal postoperative deficit, for treatment of drug‐resistant epilepsy. There is accumulating evidence suggesting that not only local, but also remote activations play an equally important role in evoking clinical effects. By introducing a new intracranial stimulation paradigm and signal analysis methodology allowing to disambiguate EEG responses from stimulation artifacts we highlight the spatial extent of the networks associated with clinical effects. Our study includes 26 patients that underwent stereoelectroencephalographic investigations for drug‐resistant epilepsy, having 337 depth electrodes with 4,351 contacts sampling most brain structures. The routine high‐frequency electrical stimulation protocol for eloquent cortex mapping was altered in a subtle way, by alternating the polarity of the biphasic pulses in a train, causing the splitting the spectral lines of the artifactual components, exposing the underlying tissue response. By performing a frequency‐domain analysis of the EEG responses during DES we were able to capture remote activations and highlight the effect's network. By using standard intersubject averaging and a fine granularity HCP‐MMP parcellation, we were able to create local and distant connectivity maps for 614 stimulations evoking specific clinical effects. The clinical value of such maps is not only for a better understanding of the extent of the effects' networks guiding the invasive exploration, but also for understanding the spatial patterns of seizure propagation given the timeline of the seizure semiology. [ABSTRACT FROM AUTHOR]

Objective: To profile European trends in pediatric epilepsy surgery (<16 years of age) between 2008 and 2015. Methods: We collected information on volumes and types of surgery, pathology, and seizure outcome from 20 recognized epilepsy surgery reference centers in 10 European countries. Results: We analyzed retrospective aggregate data on 1859 operations. The proportion of surgeries significantly increased over time (P <.0001). Engel class I outcome was achieved in 69.3% of children, with no significant improvement between 2008 and 2015. The proportion of histopathological findings consistent with glial scars significantly increased between the ages of 7 and 16 years (P for trend =.0033), whereas that of the remaining pathologies did not vary across ages. A significant increase in unilobar extratemporal surgeries (P for trend =.0047) and a significant decrease in unilobar temporal surgeries (P for trend =.0030) were observed between 2008 and 2015. Conversely, the proportion of multilobar surgeries and unrevealing magnetic resonance imaging cases remained unchanged. Invasive investigations significantly increased, especially stereo‐electroencephalography. We found different trends comparing centers starting their activity in the 1990s to those whose programs were developed in the past decade. Multivariate analysis revealed a significant variability of the proportion of the different pathologies and surgical approaches across countries, centers, and age groups between 2008 and 2015. Significance: Between 2008 and 2015, we observed a significant increase in the volume of pediatric epilepsy surgeries, stability in the proportion of Engel class I outcomes, and a modest increment in complexity of the procedures. [ABSTRACT FROM AUTHOR]

There are many medications that cross the blood-brain barrier affecting the central nervous system and converting the normal patterns of sleep and wakefulness. Some drugs are used to treat special sleep disorders but others can induce sleep disorders (e.g. periodic limb movements during sleep, restless leg syndrome, parasomnia, insomnia) or exacerbate them (e.g. obstructive or central sleep apnea). The most frequent classes of agents used in sleep medicine are: benzodiazepines, nonbenzodiazepines receptor agonists, melatonin and melatonin receptor agonists, antiepileptic drugs, antidepressants, atypical antipsychotics, central stimulants and dopamine agonists. [ABSTRACT FROM AUTHOR]

Since the Babylonian era up to nowadays, the large complexity of epileptic disorders made the attempt of classifying and organizing concepts one of the most challenging. The 1981 classification was a revision of the one devised by Henri Gastaut for the ILAE and published in 1970. The distinction between simple and complex partial seizures represented a significant difference. In 1989 the report of ILAE classification and terminology task force introduced the concept of epileptic syndrome. An epileptic syndrome is defined by the sum of signs and symptoms that tend to occur together, not reflecting a particular etiology and prognosis, these latter features being the hallmark not of a syndrome, but of a disease condition. Firstly, any epileptic disorder can be described as either idiopathic (primary, whose etiology is probably genetic), symptomatic (with a known or presumed cerebral pathology) or cryptogenic (with an occult cause). The epileptic diagnostic tree ramifies into four main branches in the 1989 ILAE Classification: localization-related (focal, local, or partial) epilepsies and syndromes, generalized epilepsies and syndromes, epilepsies and syndromes undetermined whether focal or generalized and special syndromes. The next important milestone in epilepsy classification was settled by ILAE in 2001, when a glossary for ictal semiology was developed and multiaxial approach of diagnosing epilepsy was proposed. The necessity of processing the new insights in epilepsy was answered by the latest ILAE Report released in february 2010, which brings awareness of and appropriately integrates the currently available data. It presents a modular approach of diagnosing epilepsy and recommends to keep a flexible vision on this topic, as every individual case requires a different prioritizing scheme. [ABSTRACT FROM AUTHOR]

Chronic inflammatory demyelinating polyradiculopathy is mainly based on clinical and electrophysiological criteria. If electrophysiological findings remain questionable for the diagnosis of CIDP and/or clinical presentation is atypical, nerve biopsy may assist the diagnosis. We present a case in which the nerve biopsy was helpful in diagnosis of CIDP and revealed the peculiar presence of tomacula. [ABSTRACT FROM AUTHOR]

Quantitative sensory testing (QST) is a potentially useful tool for measuring sensory impairment for clinical and research studies but there is still no consensus regarding the place of this evaluation in every day clinical practice. Our study included 15 patients previously diagnosed with neuropathic pain due to small fiber sensory polyneuropathy based on clinical and electrodiagnostic criteria.Variables were compared with an age matched control group of 7 healthy persons. We looked to pain severity rated on Visual Analog Scale and Pain Detect Questionnaire and we searched for correlations with sensory nerve conduction studies and parameters of quantitative sensory testing - thermotest, limits method. QST was a sensitive technique for evaluation of patients with small fiber sensory polyneuropathy. Score on Pain Detect Questionnaire has statistically significant correlation with values recorded for cooling detection threshold on QST, documenting sensory loss and A delta fibers dysfunction in the study group. [ABSTRACT FROM AUTHOR]

Diagnosis of ALS is based on clinical examination and electromyographic tests which are used to confirm the clinical suspicion and to exclude alternatives. Atypical presentations may delay the diagnostic and subject the patient to unnecessary tests and procedures. We discuss here three cases with atypical features: head dropping, highly focal weakness and amyotrophy and the last case with surgery for lumbar stenosis. [ABSTRACT FROM AUTHOR]

We depict the case of a patient who progressively develops a motor deficit and respiratory failure, which eventually proves to be botulinus intoxication, after a series of puzzling results of various investigations leading to a different diagnosis. [ABSTRACT FROM AUTHOR]

Dementia and depression are both frequent in stroke patients. Evaluation, follow-up of the severity and treatment decisions are important in such patients. Moreover, neuropsychological testing for cognition and mood interfere and various neurological deficits could further on alter the testing. The picture is even more complicated, considering that dementia can lead to depression and vice versa. In our current pilot study we evaluated patients in days 3-5 after the onset of ischemic stroke. We found no significant correlations between cognition and depression scores in our sample, result which suggests that at very short interval after stroke, cognitive disturbance is not a predictor for depression. [ABSTRACT FROM AUTHOR]